CD8A and cancer: These findings, together with the low direct cytotoxicity of NK cells towards B16 melanoma cells pointed to CD8+ T cells as the main cytotoxic effector lymphocytes in our model and suggested that direct cancer cell killing is unlikely to be the only mechanism via which NK cells contribute to the intracranial ICB efficacy.